During this podcast, Dr. Cercamondi will discuss the following questions:
- Based on current evidence, what is the optimal microbiome trajectory for healthy infants?
- What is the role of HMOs in that development?
- How do MOS compare to HMOs in terms of compositional and functional properties?
- What is the major difference between HMO and other Oligosaccharides such as GOS/FOS, particularly in relation to brain development?